This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Jennifer Franklin
Executive Director, CMC Regulatory Affairs at Ionis Pharmaceuticals
Speaker

Profile

Jenny has worked for Ionis Pharmaceuticals, Inc. for 19 years and for the past nine has been responsible for CMC Regulatory Affairs encompassing Ionis’ early development programs through marketing authorization and commercial lifecycle management.

Agenda Sessions

  • Practical Application of Platform Approaches for Oligonucleotides

    2:30pm